Sybille Krauss

Title: Sybille Krauss: Innovator in Medical Treatments

Introduction

Sybille Krauss is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medical treatments, particularly in addressing diseases related to microtubule-associated protein phosphatase 2A (PP2Ac). Her innovative approach has the potential to impact the lives of many individuals affected by these conditions.

Latest Patents

Sybille Krauss holds a patent titled "Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac." This invention outlines a method for preventing or treating diseases associated with abnormal intracellular levels of PP2Ac. The patent describes the administration of a pharmaceutically effective amount of proteins such as MID1 or MID2, or nucleic acids encoding these proteins, to subjects affected by these diseases.

Career Highlights

Sybille Krauss is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., a leading research institution in Germany. Her work has been instrumental in advancing the understanding of diseases linked to microtubule-associated proteins. With her innovative research, she continues to contribute to the scientific community and the development of new therapeutic methods.

Collaborations

Sybille has collaborated with notable colleagues, including Susann Schweiger and Hans-Hilger Ropers. These collaborations have fostered a productive research environment, leading to advancements in their shared field of study.

Conclusion

Sybille Krauss is a dedicated inventor whose work in medical treatments showcases her commitment to improving health outcomes. Her innovative patent and collaborations highlight her significant contributions to the scientific community.